Time to put an end to the "one size fits all" approach to bisphosphonate use in patients with metastatic breast cancer?
Bisphosphonates emerged as an effective treatment for metastatic bone disease in the mid-1990s, and in a relatively short time, they have become an integral component in the palliative care of a range of common malignancies that spread to bone[...].
Saved in:
| Published in | Current oncology (Toronto) Vol. 19; no. 5; pp. e303 - 304 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Canada
Multimed Inc
01.10.2012
|
| Online Access | Get full text |
Cover
Loading…
| Summary: | Bisphosphonates emerged as an effective treatment for metastatic bone disease in the mid-1990s, and in a relatively short time, they have become an integral component in the palliative care of a range of common malignancies that spread to bone[...]. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ISSN: | 1718-7729 1198-0052 1718-7729 |
| DOI: | 10.3747/co.19.1009 |